• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Cost Aside, Rheumatoid Arthritis Drugs Have Similar Effect

Article

Rheumatoid arthritis patients who were treated with a more costly treatment, saw no more improvement than those sought conventional treatment in reducing time off work.

Rheumatoid arthritis patients who were treated with a more costly treatment, saw no more improvement than those sought conventional treatment in reducing time off work. US News reports:

Treatment with a pricey biological drug was no better than cheaper, conventional therapy in terms of reducing time off from work for people with rheumatoid arthritis, a new study finds.

Swedish researchers assessed lost work days among rheumatoid arthritis patients who had not responded to initial treatment with a standard medication, methotrexate.

The group of 204 patients were randomly given either the biological drug infliximab (Remicade) or conventional combination therapy with the non-biologics sulfasalazine plus hydroxychloroquine.

Read the full story here: http://bit.ly/12Bc1hh

Related Videos
dr kathy zackowski
dr mitzi joi williams
dr krystyn van vliet
Hayden Klein interviews Nadine Barrett, PhD, with an AJMC On Location sign between them
Screenshot of Jennifer Vaughn, MD, in a Zoom video interview
Stephen Speicher, MD, MS
dr dalia rotstein
dr marisa mcginley
Mila Felder, MD, FACEP
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.